Relationship between expression of E-cadherin,α-catenin and biological behaviors of human pancreatic cancer
JI Xiangru
Abstract
JI Xiangru
Abstract
Objective To investigate expression of E-cadherin (E-cad) and α-catenin (α-Cat) in pancreatic carcinoma and its relationship with the biological behavior. Methods Immunohistochemistry staining (PicTure TM two steps method) was used to detect E-cad and α-Cat expression in 47 specimens of paraffin-embeded pancreatic carcinoma and 17 normal pancreas around tumors. Results E-cad and α-Cat were expressed by normal ductal and acinar cells with typical membranous staining at the intercellular junctions. 17 normal specimens of pancreas strongly expressed E-cad and α-Cat. The loss and reduction rate of E-cad expression in pancreatic carcinoma was 53.2%(25/47). The significant relationship was observed between low E-cad expression and differentiation,high hyperplastic grade and metastasis (P0.01,0.05, 0.05 and 0.01 , respectively). 61.7% (29/47) pancreatic carcinoma showed reduced or no expression of α-Cat, and there was a good correlation of α-Cat expression and histologic grade and metastasis(P0.05,0.05 and 0.01, respectively). No significant association was found between reduced expression of E-cad and α-Cat and tumor size,invasion and 1-year survival rate of patients(all P0.05). There was a positive relationship between the expression of E-cad and α-Cat in the same specimen (r=0.88,P0.01). Conclusions Pancreatic cancer presented inactivation of E-cad gene and α-Cat gene or down-regulation of E-cad and α-Cat proteins. The level of E-cad and α-Cat may be a sensitive predictor of hyperplasia, invasion and metastasis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate expression of E-cadherin (E-cad) and α-catenin (α-Cat) in pancreatic carcinoma and its relationship with the biological behavior. Methods Immunohistochemistry staining (PicTure TM two steps method) was used to detect E-cad and α-Cat expression in 47 specimens of paraffin-embeded pancreatic carcinoma and 17 normal pancreas around tumors. Results E-cad and α-Cat were expressed by normal ductal and acinar cells with typical membranous staining at the intercellular junctions. 17 normal specimens of pancreas strongly expressed E-cad and α-Cat. The loss and reduction rate of E-cad expression in pancreatic carcinoma was 53.2%(25/47). The significant relationship was observed between low E-cad expression and differentiation,high hyperplastic grade and metastasis (P0.01,0.05, 0.05 and 0.01 , respectively). 61.7% (29/47) pancreatic carcinoma showed reduced or no expression of α-Cat, and there was a good correlation of α-Cat expression and histologic grade and metastasis(P0.05,0.05 and 0.01, respectively). No significant association was found between reduced expression of E-cad and α-Cat and tumor size,invasion and 1-year survival rate of patients(all P0.05). There was a positive relationship between the expression of E-cad and α-Cat in the same specimen (r=0.88,P0.01). Conclusions Pancreatic cancer presented inactivation of E-cad gene and α-Cat gene or down-regulation of E-cad and α-Cat proteins. The level of E-cad and α-Cat may be a sensitive predictor of hyperplasia, invasion and metastasis.
Key concepts: Cadherin, Metastasis, Pancreatic cancer, Immunohistochemistry, Pathology, Pancreas, Staining, Hyperplasia